Illumina Inc (ILMN) Actualités

Annual Changes to the Nasdaq-100 Index®

NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Illumina To Webcast Upcoming Investor Conference

Illumina To Webcast Upcoming Investor Conference PR Newswire SAN DIEGO, Dec. 4, 2024 SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Illumina, Inc...

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications PR Newswire AMSTERDAM, Dec...

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic...

Illumina announces expansion of TruSight Oncology portfolio

Illumina announces expansion of TruSight Oncology portfolio PR Newswire SAN DIEGO, Nov. 19, 2024 The latest...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Illumina To Webcast Upcoming Investor Conferences

Illumina To Webcast Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 6, 2024 SAN DIEGO, Nov. 6, 2024...